Koehler Pharmaceuticals Asia Pte

Koehler Pharmaceutical Asia, a joint venture between Dr Franz Koehler Chemie GmbH and C. Melchers GmbH & Co., Singapore Branch, combines the extensive experience and resources of two renowned organisations in the pharmaceutical and healthcare sectors. Our flagship product, Custodiol® HTK solution, plays a vital role in organ transplantation by preserving and transporting donor organs with precision and efficacy. Approved for perfusion and irrigation of kidneys, liver, pancreas, and heart, Custodiol® HTK solution creates optimal conditions for successful transplantation, offering hope and saving lives. It also serves as a cardioplegia solution. By providing an optimal environment for cardiac surgeries, Custodiol® HTK solution HTK solution offers hope, saves lives, and supports critical procedures in cardiovascular surgery. We are dedicated to meeting the specific needs of our partners, providing exceptional support, tailored solutions, and unmatched service. Together, we equip healthcare professionals with the tools and resources needed to deliver patients the highest standard of care.